North America Minimal Residual Disease Testing Market

North America Minimal Residual Disease Testing Market Size, Share & Industry Trends Analysis Report By Application (Hematological Malignancies, Leukemia, Lymphoma, Solid Tumors and Others), By End User, By Technology, By Country and Growth Forecast, 2022 - 2028

Report Id: KBV-12930 Publication Date: December-2022 Number of Pages: 83
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Minimal Residual Disease Testing Market, by Application
1.4.2 North America Minimal Residual Disease Testing Market, by End User
1.4.3 North America Minimal Residual Disease Testing Market, by Technology
1.4.4 North America Minimal Residual Disease Testing Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. North America Minimal Residual Disease Testing Market by Application
3.1 North America Hematological Malignancies Market by Country
3.2 North America Leukemia Market by Country
3.3 North America Lymphoma Market by Country
3.4 North America Solid Tumors Market by Country
3.5 North America Others Market by Country

Chapter 4. North America Minimal Residual Disease Testing Market by End User
4.1 North America Hospitals & Specialty Clinics Market by Country
4.2 North America Diagnostic Laboratories Market by Country
4.3 North America Academic & Research Institutes Market by Country
4.4 North America Others Market by Country

Chapter 5. North America Minimal Residual Disease Testing Market by Technology
5.1 North America Polymerase Chain Reaction (PCR) Market by Country
5.2 North America Next-Generation Sequencing (NGS) Market by Country
5.3 North America Flow Cytometry Market by Country
5.4 North America Others Market by Country

Chapter 6. North America Minimal Residual Disease Testing Market by Country
6.1 US Minimal Residual Disease Testing Market
6.1.1 US Minimal Residual Disease Testing Market by Application
6.1.2 US Minimal Residual Disease Testing Market by End User
6.1.3 US Minimal Residual Disease Testing Market by Technology
6.2 Canada Minimal Residual Disease Testing Market
6.2.1 Canada Minimal Residual Disease Testing Market by Application
6.2.2 Canada Minimal Residual Disease Testing Market by End User
6.2.3 Canada Minimal Residual Disease Testing Market by Technology
6.3 Mexico Minimal Residual Disease Testing Market
6.3.1 Mexico Minimal Residual Disease Testing Market by Application
6.3.2 Mexico Minimal Residual Disease Testing Market by End User
6.3.3 Mexico Minimal Residual Disease Testing Market by Technology
6.4 Rest of North America Minimal Residual Disease Testing Market
6.4.1 Rest of North America Minimal Residual Disease Testing Market by Application
6.4.2 Rest of North America Minimal Residual Disease Testing Market by End User
6.4.3 Rest of North America Minimal Residual Disease Testing Market by Technology

Chapter 7. Company Profiles
7.1 Bio-Rad Laboratories, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expenses
7.2 Guardant Health, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Partnerships, Collaborations, and Agreements:
7.2.5.2 Product Launches and Product Expansions:
7.3 Invitae Corporation (ArcherDX, Inc.)
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expenses
7.3.5 Recent strategies and developments:
7.3.5.1 Partnerships, Collaborations, and Agreements:
7.4 Bio-Techne Corporation
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expenses
7.5 F. Hoffmann-La Roche Ltd.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Approvals & Trails:
7.6 ICON plc (MolecularMD Corporation)
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Regional Analysis
7.6.4 Recent strategies and developments:
7.6.4.1 Partnerships, Collaborations, and Agreements:
7.7 Natera Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expenses
7.8 Sysmex Corporation
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional Analysis
7.8.4 Research & Development Expense
7.9 Laboratory Corporation of America Holdings
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental Analysis
7.9.4 Recent strategies and developments:
7.9.4.1 Partnerships, Collaborations, and Agreements:
7.9.4.2 Product Launches and Product Expansions:
7.10. Invivoscribe, Inc.
7.10.1 Company Overview
7.10.2 Recent strategies and developments:
7.10.2.1 Partnerships, Collaborations, and Agreements:
HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 600-5072

SPECIAL PRICING & DISCOUNTS


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings


  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo